In vitro T cell proliferation and IFNγ production has been observed in response to polyclonal B cells purified from PBMCs and cultured with CD40L and tumour cell lysates.17 Similarly, CD40-activated B cells loaded with myeloma lysates were capable of activating myeloma antigen-specific T cells invitro. This evidence concerns the gene CD40 and neoplasm.